MAGMA
30 Nov 2021
Trial Summary
The Multi-Arm GlioblastoMa Australasia (MAGMA) Trial is a platform trial that will assess a number of options in standard of care for the management of glioblastoma.
Acronym:
MAGMA
ACTRN/NCT /ethics:
ACTRN12620000048987
Scientific title:
A multi-arm multi-stage, multi-centre, phase III (MAMS) platform trial that aims to assess hypotheses against a common standard-of-care control arm for the management of people with glioblastoma.
Sponsor / Cooperative group:
Medical Research Future Fund
Trial & Patient Characteristics
| Cancer Type | Brain & central nervous system |
|---|---|
| Trial Type | Treatment |
| Phase | Phase II |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | All stages |
| Anticipated Start Date | 2020-09-15 |
| Anticipated End Date | 2023-06-30 |
Participating Hospitals
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Alison Richards |
| Alison.Richards@sa.gov.au | |
| Phone | 08 8206 4835 |
| Principal Investigator | Dr Anna Mislang |
| Recruitment Status | Recruiting |